FDA Inspection
InvaTech Pharma Solutions, LLCInvaTech Pharma Solutions, LLC – FDA Inspection, Dec 28, 2017
Record Details
This FDA Inspection record concerns InvaTech Pharma Solutions, LLC, with an inspection on December 28, 2017, issued by the New Jersey District Office, covering human drugs.
- Person
View Company Profile
ID · ce10c60e-7ed5-41e3-a659-543452661698
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1036723
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of InvaTech Pharma Solutions, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 13, 2026 | Not classified | New Jersey District Office | Drug Quality Assurance |
| June 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2017 | Not classified | New Jersey District Office | |
| November 8, 2016 | Not classified | New Jersey District Office |
Other documents for InvaTech Pharma Solutions, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.